Ilaris (canakinumab) 150 mg powder for solution for injection, 1 vial — original (Novartis) Indications for the use of Ilaris include: acute gouty arthritis Drug delivery from Europe and beyond, within 4-5 days, +380996042415 Viber, WhatsApp.
Indications for use
Indications for use of Ilaris are: acute gouty arthritis: treatment of frequent acute attacks of gouty arthritis and prevention of new attacks in case of ineffectiveness, intolerance, or contraindications to the use of NSAIDs and/or colchicine and the impossibility of repeated courses of GCS; cryopyrin-associated periodic syndrome in adults and children aged ?2 years, including: familial cold autoinflammatory syndrome/familial cold urticaria; Muckle-Wells syndrome; infantile multisystem inflammatory disease/chronic infantile neurologic cutaneous-articular syndrome; active phase of systemic juvenile idiopathic arthritis in children aged ?2 years.
- Trade Name:Ilaris
- Chemical Name:Canakinumab
- Dosage:150
- Quantity:1
- Form of Issue:Flacon
No reviews yet